Connection
Christopher Lieu to Indoles
This is a "connection" page, showing publications Christopher Lieu has written about Indoles.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.719 |
|
|
|
-
Lieu CH, Lenz HJ, Benson AB, Meng X, Kim UI, Kim SH, Kim K, Sung MJ. A First-In-Human Dose-Escalation Phase I Study of Basroparib, a Tankyrase Inhibitor, in Patients with Advanced-Stage Solid Tumors. Cancer Res Commun. 2025 Oct 01; 5(10):1771-1778.
Score: 0.719